EMEA (Europe, Middle East and Africa) Oral Proteins and Peptides Market Report 2018

January 2018 | 106 pages | ID: EE4B17D203AEN
QYResearch

Abstracts

In this report, the EMEA Oral Proteins and Peptides market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (MT), revenue (Million USD), market share and growth rate of Oral Proteins and Peptides for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Oral Proteins and Peptides market competition by top manufacturers/players, with Oral Proteins and Peptides sales volume (MT), price (USD/Kg), revenue (Million USD) and market share for each manufacturer/player; the top players including

• ZydusCadilla Healthcare
• Sanofi-Aventis LLC
• Roche, Inc.
• Pfizer, Inc.
• Novartis AG
• Johnson & Johnson
• Abbott Laboratories

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• Linaclotide
• Plecanatide
• Octreolin

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Medicine
• Healthcare

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Oral Proteins and Peptides Market Report 2017

1 ORAL PROTEINS AND PEPTIDES OVERVIEW

1.1 Product Overview and Scope of Oral Proteins and Peptides
1.2 Classification of Oral Proteins and Peptides
  1.2.1 EMEA Oral Proteins and Peptides Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Oral Proteins and Peptides Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Linaclotide
  1.2.4 Plecanatide
  1.2.5 Octreolin
1.3 EMEA Oral Proteins and Peptides Market by Application/End Users
  1.3.1 EMEA Oral Proteins and Peptides Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Medicine
  1.3.3 Healthcare
1.4 EMEA Oral Proteins and Peptides Market by Region
  1.4.1 EMEA Oral Proteins and Peptides Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Oral Proteins and Peptides (2012-2022)
  1.5.1 EMEA Oral Proteins and Peptides Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Oral Proteins and Peptides Revenue and Growth Rate (2012-2022)

2 EMEA ORAL PROTEINS AND PEPTIDES COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Oral Proteins and Peptides Market Competition by Players/Manufacturers
  2.1.1 EMEA Oral Proteins and Peptides Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Oral Proteins and Peptides Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Oral Proteins and Peptides Sale Price by Players (2012-2017)
2.2 EMEA Oral Proteins and Peptides (Volume and Value) by Type/Product Category
  2.2.1 EMEA Oral Proteins and Peptides Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Oral Proteins and Peptides Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Oral Proteins and Peptides Sale Price by Type (2012-2017)
2.3 EMEA Oral Proteins and Peptides (Volume) by Application
2.4 EMEA Oral Proteins and Peptides (Volume and Value) by Region
  2.4.1 EMEA Oral Proteins and Peptides Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Oral Proteins and Peptides Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Oral Proteins and Peptides Sales Price by Region (2012-2017)

3 EUROPE ORAL PROTEINS AND PEPTIDES (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Oral Proteins and Peptides Sales and Value (2012-2017)
  3.1.1 Europe Oral Proteins and Peptides Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Oral Proteins and Peptides Revenue and Growth Rate (2012-2017)
3.2 Europe Oral Proteins and Peptides Sales and Market Share by Type
3.3 Europe Oral Proteins and Peptides Sales and Market Share by Application
3.4 Europe Oral Proteins and Peptides Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Oral Proteins and Peptides Sales Volume by Countries (2012-2017)
  3.4.2 Europe Oral Proteins and Peptides Revenue by Countries (2012-2017)
  3.4.3 Germany Oral Proteins and Peptides Sales and Growth Rate (2012-2017)
  3.4.4 France Oral Proteins and Peptides Sales and Growth Rate (2012-2017)
  3.4.5 UK Oral Proteins and Peptides Sales and Growth Rate (2012-2017)
  3.4.6 Russia Oral Proteins and Peptides Sales and Growth Rate (2012-2017)
  3.4.7 Italy Oral Proteins and Peptides Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Oral Proteins and Peptides Sales and Growth Rate (2012-2017)

4 MIDDLE EAST ORAL PROTEINS AND PEPTIDES (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Oral Proteins and Peptides Sales and Value (2012-2017)
  4.1.1 Middle East Oral Proteins and Peptides Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Oral Proteins and Peptides Revenue and Growth Rate (2012-2017)
4.2 Middle East Oral Proteins and Peptides Sales and Market Share by Type
4.3 Middle East Oral Proteins and Peptides Sales and Market Share by Application
4.4 Middle East Oral Proteins and Peptides Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Oral Proteins and Peptides Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Oral Proteins and Peptides Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Oral Proteins and Peptides Sales and Growth Rate (2012-2017)
  4.4.4 Israel Oral Proteins and Peptides Sales and Growth Rate (2012-2017)
  4.4.5 UAE Oral Proteins and Peptides Sales and Growth Rate (2012-2017)
  4.4.6 Iran Oral Proteins and Peptides Sales and Growth Rate (2012-2017)

5 AFRICA ORAL PROTEINS AND PEPTIDES (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Oral Proteins and Peptides Sales and Value (2012-2017)
  5.1.1 Africa Oral Proteins and Peptides Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Oral Proteins and Peptides Revenue and Growth Rate (2012-2017)
5.2 Africa Oral Proteins and Peptides Sales and Market Share by Type
5.3 Africa Oral Proteins and Peptides Sales and Market Share by Application
5.4 Africa Oral Proteins and Peptides Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Oral Proteins and Peptides Sales Volume by Countries (2012-2017)
  5.4.2 Africa Oral Proteins and Peptides Revenue by Countries (2012-2017)
  5.4.3 South Africa Oral Proteins and Peptides Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Oral Proteins and Peptides Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Oral Proteins and Peptides Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Oral Proteins and Peptides Sales and Growth Rate (2012-2017)

6 EMEA ORAL PROTEINS AND PEPTIDES MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 ZydusCadilla Healthcare
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Oral Proteins and Peptides Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 ZydusCadilla Healthcare Oral Proteins and Peptides Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Sanofi-Aventis LLC
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Oral Proteins and Peptides Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Sanofi-Aventis LLC Oral Proteins and Peptides Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Roche, Inc.
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Oral Proteins and Peptides Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Roche, Inc. Oral Proteins and Peptides Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Pfizer, Inc.
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Oral Proteins and Peptides Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Pfizer, Inc. Oral Proteins and Peptides Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Novartis AG
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Oral Proteins and Peptides Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Novartis AG Oral Proteins and Peptides Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Johnson & Johnson
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Oral Proteins and Peptides Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Johnson & Johnson Oral Proteins and Peptides Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Abbott Laboratories
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Oral Proteins and Peptides Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Abbott Laboratories Oral Proteins and Peptides Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview

7 ORAL PROTEINS AND PEPTIDES MANUFACTURING COST ANALYSIS

7.1 Oral Proteins and Peptides Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Oral Proteins and Peptides

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Oral Proteins and Peptides Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Oral Proteins and Peptides Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA ORAL PROTEINS AND PEPTIDES MARKET FORECAST (2017-2022)

11.1 EMEA Oral Proteins and Peptides Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Oral Proteins and Peptides Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Oral Proteins and Peptides Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Oral Proteins and Peptides Price and Trend Forecast (2017-2022)
11.2 EMEA Oral Proteins and Peptides Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Oral Proteins and Peptides Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Oral Proteins and Peptides Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Oral Proteins and Peptides Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Oral Proteins and Peptides Sales Forecast by Type (2017-2022)
11.7 EMEA Oral Proteins and Peptides Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Oral Proteins and Peptides
Figure EMEA Oral Proteins and Peptides Sales Volume (MT) by Type (2012-2022)
Figure EMEA Oral Proteins and Peptides Sales Volume Market Share by Type (Product Category) in 2016
Figure Linaclotide Product Picture
Figure Plecanatide Product Picture
Figure Octreolin Product Picture
Figure EMEA Oral Proteins and Peptides Sales Volume (MT) by Application (2012-2022)
Figure EMEA Sales Market Share of Oral Proteins and Peptides by Application in 2016
Figure Medicine Examples
Table Key Downstream Customer in Medicine
Figure Healthcare Examples
Table Key Downstream Customer in Healthcare
Figure EMEA Oral Proteins and Peptides Market Size (Million USD) by Region (2012-2022)
Figure Europe Oral Proteins and Peptides Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Oral Proteins and Peptides Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Oral Proteins and Peptides Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Oral Proteins and Peptides Revenue (Million USD) Status and Forecast by Countries
Figure Africa Oral Proteins and Peptides Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Oral Proteins and Peptides Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Oral Proteins and Peptides Sales Volume and Growth Rate (2012-2022)
Figure EMEA Oral Proteins and Peptides Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Oral Proteins and Peptides Market Major Players Product Sales Volume (MT) (2012-2017)
Table EMEA Oral Proteins and Peptides Sales Volume (MT) of Major Players (2012-2017)
Table EMEA Oral Proteins and Peptides Sales Share by Players (2012-2017)
Figure 2016 Oral Proteins and Peptides Sales Share by Players
Figure 2017 Oral Proteins and Peptides Sales Share by Players
Figure EMEA Oral Proteins and Peptides Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Oral Proteins and Peptides Revenue (Million USD) by Players (2012-2017)
Table EMEA Oral Proteins and Peptides Revenue Share by Players (2012-2017)
Table 2016 EMEA Oral Proteins and Peptides Revenue Share by Players
Table 2017 EMEA Oral Proteins and Peptides Revenue Share by Players
Table EMEA Oral Proteins and Peptides Sale Price (USD/Kg) by Players (2012-2017)
Table EMEA Oral Proteins and Peptides Sales (MT) and Market Share by Type (2012-2017)
Table EMEA Oral Proteins and Peptides Sales Share by Type (2012-2017)
Figure Sales Market Share of Oral Proteins and Peptides by Type (2012-2017)
Figure EMEA Oral Proteins and Peptides Sales Market Share by Type (2012-2017)
Table EMEA Oral Proteins and Peptides Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Oral Proteins and Peptides Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Oral Proteins and Peptides by Type in 2016
Table EMEA Oral Proteins and Peptides Sale Price (USD/Kg) by Type (2012-2017)
Table EMEA Oral Proteins and Peptides Sales (MT) and Market Share by Application (2012-2017)
Table EMEA Oral Proteins and Peptides Sales Share by Application (2012-2017)
Figure Sales Market Share of Oral Proteins and Peptides by Application (2012-2017)
Figure EMEA Oral Proteins and Peptides Sales Market Share by Application in 2016
Table EMEA Oral Proteins and Peptides Sales (MT) and Market Share by Region (2012-2017)
Table EMEA Oral Proteins and Peptides Sales Share by Region (2012-2017)
Figure Sales Market Share of Oral Proteins and Peptides by Region (2012-2017)
Figure EMEA Oral Proteins and Peptides Sales Market Share in 2016
Table EMEA Oral Proteins and Peptides Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Oral Proteins and Peptides Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Oral Proteins and Peptides by Region (2012-2017)
Figure EMEA Oral Proteins and Peptides Revenue Market Share Regions in 2016
Table EMEA Oral Proteins and Peptides Sales Price (USD/Kg) by Region (2012-2017)
Figure Europe Oral Proteins and Peptides Sales (MT) and Growth Rate (2012-2017)
Figure Europe Oral Proteins and Peptides Revenue and Growth Rate (2012-2017)
Table Europe Oral Proteins and Peptides Sales (MT) by Type (2012-2017)
Table Europe Oral Proteins and Peptides Market Share by Type (2012-2017)
Figure Europe Oral Proteins and Peptides Market Share by Type in 2016
Table Europe Oral Proteins and Peptides Sales (MT) by Application (2012-2017)
Table Europe Oral Proteins and Peptides Market Share by Application (2012-2017)
Figure Europe Oral Proteins and Peptides Market Share by Application in 2016
Table Europe Oral Proteins and Peptides Sales (MT) by Countries (2012-2017)
Table Europe Oral Proteins and Peptides Sales Market Share by Countries (2012-2017)
Figure Europe Oral Proteins and Peptides Sales Market Share by Countries (2012-2017)
Figure Europe Oral Proteins and Peptides Sales Market Share by Countries in 2016
Table Europe Oral Proteins and Peptides Revenue (Million USD) by Countries (2012-2017)
Table Europe Oral Proteins and Peptides Revenue Market Share by Countries (2012-2017)
Figure Europe Oral Proteins and Peptides Revenue Market Share by Countries (2012-2017)
Figure Europe Oral Proteins and Peptides Revenue Market Share by Countries in 2016
Figure Germany Oral Proteins and Peptides Sales (MT) and Growth Rate (2012-2017)
Figure France Oral Proteins and Peptides Sales (MT) and Growth Rate (2012-2017)
Figure UK Oral Proteins and Peptides Sales (MT) and Growth Rate (2012-2017)
Figure Russia Oral Proteins and Peptides Sales (MT) and Growth Rate (2012-2017)
Figure Italy Oral Proteins and Peptides Sales (MT) and Growth Rate (2012-2017)
Figure Benelux Oral Proteins and Peptides Sales (MT) and Growth Rate (2012-2017)
Figure Middle East Oral Proteins and Peptides Sales (MT) and Growth Rate (2012-2017)
Figure Middle East Oral Proteins and Peptides Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Oral Proteins and Peptides Sales (MT) by Type (2012-2017)
Table Middle East Oral Proteins and Peptides Market Share by Type (2012-2017)
Figure Middle East Oral Proteins and Peptides Market Share by Type (2012-2017)
Table Middle East Oral Proteins and Peptides Sales (MT) by Applications (2012-2017)
Table Middle East Oral Proteins and Peptides Market Share by Applications (2012-2017)
Figure Middle East Oral Proteins and Peptides Sales Market Share by Application in 2016
Table Middle East Oral Proteins and Peptides Sales Volume (MT) by Countries (2012-2017)
Table Middle East Oral Proteins and Peptides Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Oral Proteins and Peptides Sales Volume Market Share by Countries in 2016
Table Middle East Oral Proteins and Peptides Revenue (Million USD) by Countries (2012-2017)
Table Middle East Oral Proteins and Peptides Revenue Market Share by Countries (2012-2017)
Figure Middle East Oral Proteins and Peptides Revenue Market Share by Countries (2012-2017)
Figure Middle East Oral Proteins and Peptides Revenue Market Share by Countries in 2016
Figure Saudi Arabia Oral Proteins and Peptides Sales (MT) and Growth Rate (2012-2017)
Figure Israel Oral Proteins and Peptides Sales (MT) and Growth Rate (2012-2017)
Figure UAE Oral Proteins and Peptides Sales (MT) and Growth Rate (2012-2017)
Figure Iran Oral Proteins and Peptides Sales (MT) and Growth Rate (2012-2017)
Figure Africa Oral Proteins and Peptides Sales (MT) and Growth Rate (2012-2017)
Figure Africa Oral Proteins and Peptides Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Oral Proteins and Peptides Sales (MT) by Type (2012-2017)
Table Africa Oral Proteins and Peptides Sales Market Share by Type (2012-2017)
Figure Africa Oral Proteins and Peptides Sales Market Share by Type (2012-2017)
Figure Africa Oral Proteins and Peptides Sales Market Share by Type in 2016
Table Africa Oral Proteins and Peptides Sales (MT) by Application (2012-2017)
Table Africa Oral Proteins and Peptides Sales Market Share by Application (2012-2017)
Figure Africa Oral Proteins and Peptides Sales Market Share by Application (2012-2017)
Table Africa Oral Proteins and Peptides Sales Volume (MT) by Countries (2012-2017)
Table Africa Oral Proteins and Peptides Sales Market Share by Countries (2012-2017)
Figure Africa Oral Proteins and Peptides Sales Market Share by Countries (2012-2017)
Figure Africa Oral Proteins and Peptides Sales Market Share by Countries in 2016
Table Africa Oral Proteins and Peptides Revenue (Million USD) by Countries (2012-2017)
Table Africa Oral Proteins and Peptides Revenue Market Share by Countries (2012-2017)
Figure Africa Oral Proteins and Peptides Revenue Market Share by Countries (2012-2017)
Figure Africa Oral Proteins and Peptides Revenue Market Share by Countries in 2016
Figure South Africa Oral Proteins and Peptides Sales (MT) and Growth Rate (2012-2017)
Figure Nigeria Oral Proteins and Peptides Sales (MT) and Growth Rate (2012-2017)
Figure Egypt Oral Proteins and Peptides Sales (MT) and Growth Rate (2012-2017)
Figure Algeria Oral Proteins and Peptides Sales (MT) and Growth Rate (2012-2017)
Table ZydusCadilla Healthcare Oral Proteins and Peptides Basic Information List
Table ZydusCadilla Healthcare Oral Proteins and Peptides Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure ZydusCadilla Healthcare Oral Proteins and Peptides Sales (MT) and Growth Rate (2012-2017)
Figure ZydusCadilla Healthcare Oral Proteins and Peptides Sales Market Share in EMEA (2012-2017)
Figure ZydusCadilla Healthcare Oral Proteins and Peptides Revenue Market Share in EMEA (2012-2017)
Table Sanofi-Aventis LLC Oral Proteins and Peptides Basic Information List
Table Sanofi-Aventis LLC Oral Proteins and Peptides Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Sanofi-Aventis LLC Oral Proteins and Peptides Sales (MT) and Growth Rate (2012-2017)
Figure Sanofi-Aventis LLC Oral Proteins and Peptides Sales Market Share in EMEA (2012-2017)
Figure Sanofi-Aventis LLC Oral Proteins and Peptides Revenue Market Share in EMEA (2012-2017)
Table Roche, Inc. Oral Proteins and Peptides Basic Information List
Table Roche, Inc. Oral Proteins and Peptides Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Roche, Inc. Oral Proteins and Peptides Sales (MT) and Growth Rate (2012-2017)
Figure Roche, Inc. Oral Proteins and Peptides Sales Market Share in EMEA (2012-2017)
Figure Roche, Inc. Oral Proteins and Peptides Revenue Market Share in EMEA (2012-2017)
Table Pfizer, Inc. Oral Proteins and Peptides Basic Information List
Table Pfizer, Inc. Oral Proteins and Peptides Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Pfizer, Inc. Oral Proteins and Peptides Sales (MT) and Growth Rate (2012-2017)
Figure Pfizer, Inc. Oral Proteins and Peptides Sales Market Share in EMEA (2012-2017)
Figure Pfizer, Inc. Oral Proteins and Peptides Revenue Market Share in EMEA (2012-2017)
Table Novartis AG Oral Proteins and Peptides Basic Information List
Table Novartis AG Oral Proteins and Peptides Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Novartis AG Oral Proteins and Peptides Sales (MT) and Growth Rate (2012-2017)
Figure Novartis AG Oral Proteins and Peptides Sales Market Share in EMEA (2012-2017)
Figure Novartis AG Oral Proteins and Peptides Revenue Market Share in EMEA (2012-2017)
Table Johnson & Johnson Oral Proteins and Peptides Basic Information List
Table Johnson & Johnson Oral Proteins and Peptides Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Johnson & Johnson Oral Proteins and Peptides Sales (MT) and Growth Rate (2012-2017)
Figure Johnson & Johnson Oral Proteins and Peptides Sales Market Share in EMEA (2012-2017)
Figure Johnson & Johnson Oral Proteins and Peptides Revenue Market Share in EMEA (2012-2017)
Table Abbott Laboratories Oral Proteins and Peptides Basic Information List
Table Abbott Laboratories Oral Proteins and Peptides Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Abbott Laboratories Oral Proteins and Peptides Sales (MT) and Growth Rate (2012-2017)
Figure Abbott Laboratories Oral Proteins and Peptides Sales Market Share in EMEA (2012-2017)
Figure Abbott Laboratories Oral Proteins and Peptides Revenue Market Share in EMEA (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Oral Proteins and Peptides
Figure Manufacturing Process Analysis of Oral Proteins and Peptides
Figure Oral Proteins and Peptides Industrial Chain Analysis
Table Raw Materials Sources of Oral Proteins and Peptides Major Manufacturers in 2016
Table Major Buyers of Oral Proteins and Peptides
Table Distributors/Traders List
Figure EMEA Oral Proteins and Peptides Sales (MT) and Growth Rate Forecast (2017-2022)
Figure EMEA Oral Proteins and Peptides Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Oral Proteins and Peptides Price (USD/Kg) and Trend Forecast (2017-2022)
Table EMEA Oral Proteins and Peptides Sales (MT) Forecast by Region (2017-2022)
Figure EMEA Oral Proteins and Peptides Sales Market Share Forecast by Region (2017-2022)
Table EMEA Oral Proteins and Peptides Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Oral Proteins and Peptides Revenue Market Share Forecast by Region (2017-2022)
Table Europe Oral Proteins and Peptides Sales (MT) Forecast by Countries (2017-2022)
Figure Europe Oral Proteins and Peptides Sales Market Share Forecast by Countries (2017-2022)
Table Europe Oral Proteins and Peptides Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Oral Proteins and Peptides Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Oral Proteins and Peptides Sales (MT) Forecast by Countries (2017-2022)
Figure Middle East Oral Proteins and Peptides Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Oral Proteins and Peptides Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Oral Proteins and Peptides Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Oral Proteins and Peptides Sales (MT) Forecast by Countries (2017-2022)
Figure Africa Oral Proteins and Peptides Sales Market Share Forecast by Countries (2017-2022)
Table Africa Oral Proteins and Peptides Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Oral Proteins and Peptides Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Oral Proteins and Peptides Sales (MT) Forecast by Type (2017-2022)
Figure EMEA Oral Proteins and Peptides Sales Market Share Forecast by Type (2017-2022)
Table EMEA Oral Proteins and Peptides Sales (MT) Forecast by Application (2017-2022)
Figure EMEA Oral Proteins and Peptides Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources